Implementation of Evidence-based Breathing Retraining for Patients with Asthma in Region Zealand

Summary

This study aims to implement the evidence-based intervention breathing retraining into clinical care of patients with symptomatic asthma irrespective of asthma severity or comorbidities, and in a diverse multicentre setting to evaluate implementation outcomes. This will meet patients' needs and improve health and life situation in patients with uncontrolled asthma. Further, the study will evaluate implementation outcomes.

Conditions

• Asthma

Interventions

OTHER

Breathing Retraining

Conforming the real-world setting, all participants will continue standard asthma care, i.e., acute and planned visits at GP or pulmonologist. BR aims to normalize the inhaled volume, nasal inhalation, exhalation to the resting position of the chest (functional residual capacity, FRC), use of the diaphragm muscle, and to move lower parts of the chest in a frequency of 12-16 per minute. This pattern is initially trained in rest (e.g., side lying or sitting), then during physical activity (e.g., walking). Uncontrolled coughing, frequent yawning or sighing is handled by a suppression technique. Relaxation technique is introduced as a separate activity but to be combined with the breathing pattern method to be used in both resting and as possible during physical activity.

Sponsors & Collaborators

• Naestved Hospital

  lead OTHER

Principal Investigators

• Søren T Skou, Prof. · Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark

• Lars H Tang, Assoc.Prof. · Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark

• Cecilie L Egholm, PostDoc. · Naestved-Slagelse-Ringsted Hospitals, Denmark

• Uffe Bodtger, Prof. · Zealand University Hospital; University of Southern Denmark

• Mike Thomas, Prof. · Primary Care Research University of Southampton, UK

• Karen H Andreasson, Dr. · Naestved-Slagelse-Ringsted Hospitals; University of Southern Denmark

Study Design

Allocation

NA

Purpose

OTHER

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-06-30

Primary Completion

2025-12-31

Completion

2025-12-31

Countries

• Denmark

Study Locations